Ahead of Optomeds's Q3-report (to be published on 6 november), investors on Pinpoint Estimates expect revenues and earnings within the following weighted ranges:

Net sales: 3.66 - 4.07 MEUR
Previous outcome (2024-Q3): 3.1 MEUR

EBIT: (-1.21) - (-0.81) MEUR
Previous outcome (2024-Q3): (-1.4) MEUR

The data is based on 8 investors estimates. Visit pinpointestimates.com to access Pinpoint's consensus figure and other investors' estimates ahead of the report.

Pinpoint Estimates is a platform that compiles estimates from private investors and analysts before publicly traded companies' reports. The estimates are weighted based on each user's historical accuracy and compiled into a consensus.

Access Pinpoint's consensus for Optomeds quarterly and annual results at pinpointestimates.com.

Läs mer på Pinpoint Estimates

Ämnen i artikeln

Optomed

Senast

4,00

1 dag %

1,27%

1 dag

1 mån

1 år

Marknadsöversikt

OMX Stockholm 30

1 DAG %

0,08%

Senast

2 704,05

1 mån
Loading market data...